Ramipril-associated lichen planus pemphigoides

British Journal of Dermatology

Volumn 136, Issue 3, 1997, Pages 412-414

  Ogg, G S ^a   Bhogal, B S ^a   Hashimoto, T ^b   Coleman, R ^a   Barker, J N W N ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; NIFEDIPINE; PREDNISOLONE; RAMIPRIL;

ADULT; ARTICLE; CASE REPORT; ESSENTIAL HYPERTENSION; HUMAN; HUMAN TISSUE; LICHEN PLANUS; MALE; PEMPHIGOID; PRIORITY JOURNAL;

EID: 0031043662     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb14956.x     Document Type: Article

References (10)

1. Davis AL, Bhogal BS, Whitehead P et al. Lichen planus pemphigoides: its relationship to bullous pemphigoid. Br J Dermatol 1991; 125: 263-71.
2. Souteyrand P, Pierini AM, Fernandez Bussy R et al. Lichen planus pemphigoides. Entity or association? Dermatologica 1981; 162: 414-16.
3. Hintner H, Tappeiner G, Honigsmann H, Wolff K. Lichen planus and bullous pemphigoid. Acta Derm Venereol (Stockh) 1979; 59 (Suppl.): 71-6.
4. Prost C, Tesserand F, Laroche L et al. Lichen planus pemphigoides: an immunoelectron microscopic study. Br J Dermatol 1985; 113: 31-6.
5. Okada N, Kitano Y, Miyagawa S et al. Expression of pemphigoid antigen by SV40-transformed human keratinocytes. J Invest Dermatol 1986; 86: 399-401.
6. Kirtschig G, Wojnarowska F. Autoimmune blistering diseases: an up-date of diagnostic methods and investigations. Clin Exp Dermatol 1994; 19: 97-112.
7. Flageul B, Foldes C, Wallach D et al. Captopril-induced lichen planus pemphigoides with pemphigus-like features. Dermatologica 1986; 173: 248-55.
8. Giudice GJ, Emery DJ, Zelickson BD et al. Bullous pemphigoid and herpes gestationis autoantibodies recognise a common non-collagenous site on the BP180 ectodomain. J Immunol 1993; 151: 5742-50.
9. Matsumara K, Amagai M, Nishikawa T, Hashimoto T. Majority of bullous pemphigoid and herpes gestationis sera react with NC16a domain of the 180kD bullous pemphigoid antigen. Arch Dermatol Res (in press).
10. Bodmer H, Ogg GS, Gotch F, McMichael AJ. Anti-HLA-A2·1 monoclonal antibody enhances recognition of target cells by cytotoxic T lymphocytes. Nature 1989; 342: 443-6.